Related Experiment Videos
Continuous subcutaneous injection reduces polymorphonuclear leukocyte activation by granulocyte colony-stimulating
Yukio Sato1, Yukinobu Goto, Shoko Sato
1Division of Thoracic Surgery, Department of Surgery, Jichi Medical School, 3311-1 Minamikawachi, Kawachi, Tochigi 329-0498, Japan. tcvysato@jichi.ac.jp
Summary
Continuous G-CSF administration reduces polymorphonuclear leukocyte (PMN) activation compared to single injections. This finding is crucial for minimizing G-CSF-related lung injury risks during neutropenia recovery.
Area of Science:
- Hematology
- Pharmacology
- Immunology
Background:
- Granulocyte colony-stimulating factor (G-CSF) is vital for neutropenia recovery.
- G-CSF-induced polymorphonuclear leukocyte (PMN) activation can cause acute lung injury.
- Optimizing G-CSF administration is key to mitigating adverse effects.
Purpose of the Study:
- To compare PMN activation between single bolus (SI) and continuous infusion (CI) G-CSF administration.
- To evaluate the safety and efficacy of different G-CSF delivery methods.
- To investigate G-CSF's impact on leukocyte counts and inflammatory markers.
Main Methods:
- Healthy volunteers received either SI or CI of G-CSF.
- Leukocyte counts, PMN activation markers (CD11b, L-selectin, F-actin), and serum G-CSF, IL-6, and PMN elastase were measured.
- Data were collected over a 48-hour follow-up period.
Main Results:
- Continuous G-CSF (CI) showed attenuated PMN activation compared to single injection (SI).
- SI led to rapid G-CSF peaks and significant PMN activation markers.
- CI resulted in sustained G-CSF levels and reduced inflammatory responses (IL-6, PMN elastase).
Conclusions:
- Continuous subcutaneous G-CSF administration reduces PMN activation while maintaining marrow response.
- CI may offer a safer alternative to SI for G-CSF therapy, minimizing lung injury risk.
- Further research should explore optimal G-CSF dosing strategies for clinical use.